With GUARDUS, ZEISS Acquires a Software Supplier for Analysis and Management in Production

OBERKOCHEN/Germany, ULM/Germany, 2018-04-24. ZEISS and GUARDUS have announced that the software solutions supplier for computer-supported quality assurance and production management systems based in the German city of Ulm has become a wholly owned subsidiary of the ZEISS Group. For ZEISS, the integration of GUARDUS into its Industrial Metrology (IMT) business group will further strengthen its... Read more

BD Unveils Suite of Diagnostic Informatics and Automation Innovations

FRANKLIN LAKES, N.J., April 19, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance. The new molecular, microbiology and software solutions will be showcased... Read more

MIT Spinout, ReviveMed, Raises $1.5M to Advance its AI-Driven Metabolomic Platform for Drug Discovery

Cambridge, MA – April 18, 2018 ReviveMed Inc., today announced it has closed an oversubscribed seed round of $1.5 million to advance its artificial intelligence (AI)-driven platform that unlocks the value of metabolomics data for drug discovery and development. Rivas Capital led the round, which also included participation from several institutional investors including TechU, Team... Read more

WuXi NextCODE Names Richard Williams to Lead Cancer Genomics Business

Dr Richard Williams, managing director and head of oncology at WuXi NextCODE SHANGHAI and CAMBRIDGE, Mass. and REYKJAVIK, Iceland, April 15, 2018 /PRNewswire/ — At AACR, Williams and colleagues will showcase the company’s portfolio of cutting edge capabilities for using genomic data to optimize and advance cancer therapies: Liberating the world’s largest cancer datasets with the novel SeqPlusSM method for high-quality sequencing... Read more

PDS Life Sciences Selects Vicente Nogués as new CEO

Pratteln, Switzerland; April 13, 2018 – PDS Life Sciences, a global provider of software and solutions dedicated to Preclinical Research and Development, has announced the appointment of Vicente Nogués, PhD, as the new CEO effective April 10, 2018. Dr. Nogués will be based in Basel, Switzerland. Vince will be instrumental in providing scientific and operational leadership to PDS.... Read more

Coming Soon to the Siemens Healthineers Aptio Automation System: iSpecimen Integrated Solution

— Scientists require human biofluid, tissue and cell specimens that meet precise requirements to advance biomedical research, but often have difficulty locating the specific patient samples they need. — iSpecimen works with laboratories to compliantly aggregate for researchers remnant human samples that would otherwise be discarded. — Using the CentraLink Data Management System and Aptio... Read more

St. Jude Cloud, largest public repository of pediatric cancer genomics data, launches for researchers worldwide

St. Jude Children’s Research Hospital, in collaboration with Microsoft and DNAnexus, offers extensive next-generation sequencing data and unique analysis tools to accelerate research and cures for life-threatening pediatric diseases.   Memphis, Tennessee, April 12, 2018 St. Jude Children’s Research Hospital today launched St. Jude Cloud, an online data-sharing and collaboration platform that provides researchers access to the world’s largest... Read more

WuXi NextCODE Announces Executive Leadership Transition

Rob Brainin appointed as CEO to lead next phase of global growth, succeeding co-founder Hannes Smárason, who will continue as senior advisor SHANGHAI, CAMBRIDGE, Mass. and REYKJAVIK, Iceland, March 12, 2018 /PRNewswire/ — WuXi  NextCODE, the emerging global platform for genomic data, today announced that Rob Brainin, Executive Vice President and Chief Operating Officer, has been appointed as the company’s new Chief Executive... Read more